©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Eyewire News: The Podcast
Eyewire Podcast Logo Outlined
Eyewire News: The Podcast

12.17.25

Update on Reproxalap PDUFA Timing

Aldeyra provides an update on the timing of its dry eye disease treatment candidate reproxalap; Ocular Therapeutix pursues an accelerated NDA pathway for wet AMD therapy Axpaxli; and companies with late-stage drug candidates announce FDA submission plans.  Learn more about your ad choices. Visit megaphone.fm/adchoices

View full description +

MORE EPISODES

12.31.25

2025 Year in Review - Part 2

12.24.25

2025 Year in Review - Part 1

12.17.25

Update on Reproxalap PDUFA Timing

12.10.25

New Glaucoma Technologies Advance in Clinical Development

12.03.25

Eylea HD Approved for RVO and Extended Dosing

11.26.25

Leaders Discuss Emerging Technologies in Glaucoma

11.18.25

Live Coverage of B+L Investor Day

11.12.25

Ryjunea Approved in the UK for Myopia

Show More

Anterior 3D Cataract Cornea General Glaucoma Optometry Pediatric Refractive/LVC Residents & Fellows Retina Retina 3D
close-x